China Pharma Holdings, Inc. (CPHI) stock
CPHINYSEPharmaceutical PreparationsFiscal year ends December 31
$0.54−0.01 (-1.43%)
Close on Nov 11, 2026Market cap $23.37MP/E –Yield –
China Pharma cash
Cash and short-term investments held at the end of each period.
China Pharma's cash was $304.87K at Jun 30, 2026. For fiscal 2025 it was $345.11K, down 44.9% from the year before. Over ten years it grew -25.1% a year on average. The highest annual figure on record is $6.25M in fiscal 2015.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $345.11K | -44.9% |
| FY2024 | Dec 31, 2024 | $626.88K | -56.0% |
| FY2023 | Dec 31, 2023 | $1.42M | -29.9% |
| FY2022 | Dec 31, 2022 | $2.03M | -58.2% |
| FY2021 | Dec 31, 2021 | $4.86M | +462.1% |
| FY2020 | Dec 31, 2020 | $864.48K | -27.0% |
| FY2019 | Dec 31, 2019 | $1.18M | -51.8% |
| FY2018 | Dec 31, 2018 | $2.46M | 0.0% |
| FY2017 | Dec 31, 2017 | $2.46M | -7.7% |
| FY2016 | Dec 31, 2016 | $2.67M | -57.3% |
| FY2015 | Dec 31, 2015 | $6.25M | +18.0% |
| FY2014 | Dec 31, 2014 | $5.30M | -11.6% |
| FY2013 | Dec 31, 2013 | $5.99M | +48.7% |
| FY2012 | Dec 31, 2012 | $4.03M | -0.5% |
| FY2011 | Dec 31, 2011 | $4.05M | +9.7% |
| FY2010 | Dec 31, 2010 | $3.69M | +1.6% |
| FY2009 | Dec 31, 2009 | $3.63M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $304.87K | -51.2% |
| Q1 FY2026 | Mar 31, 2026 | $168.47K | -59.2% |
| Q4 FY2025 | Dec 31, 2025 | $345.11K | -44.9% |
| Q3 FY2025 | Sep 30, 2025 | $267.63K | -62.8% |
| Q2 FY2025 | Jun 30, 2025 | $625.03K | -15.5% |
| Q1 FY2025 | Mar 31, 2025 | $412.69K | -50.8% |
| Q4 FY2024 | Dec 31, 2024 | $626.88K | -56.0% |
| Q3 FY2024 | Sep 30, 2024 | $718.69K | -47.5% |
| Q2 FY2024 | Jun 30, 2024 | $739.34K | -18.0% |
| Q1 FY2024 | Mar 31, 2024 | $838.88K | -28.1% |
| Q4 FY2023 | Dec 31, 2023 | $1.42M | -29.9% |
| Q3 FY2023 | Sep 30, 2023 | $1.37M | -34.3% |
| Q2 FY2023 | Jun 30, 2023 | $901.91K | -59.8% |
| Q1 FY2023 | Mar 31, 2023 | $1.17M | -68.6% |
| Q4 FY2022 | Dec 31, 2022 | $2.03M | -58.2% |
| Q3 FY2022 | Sep 30, 2022 | $2.09M | +354.7% |
| Q2 FY2022 | Jun 30, 2022 | $2.24M | +27.9% |
| Q1 FY2022 | Mar 31, 2022 | $3.71M | +595.0% |
| Q4 FY2021 | Dec 31, 2021 | $4.86M | +462.1% |
| Q3 FY2021 | Sep 30, 2021 | $458.83K | +32.4% |
| Q2 FY2021 | Jun 30, 2021 | $1.75M | -3.2% |
| Q1 FY2021 | Mar 31, 2021 | $534.53K | +266.3% |
| Q4 FY2020 | Dec 31, 2020 | $864.48K | -27.0% |
| Q3 FY2020 | Sep 30, 2020 | $346.61K | -54.5% |
| Q2 FY2020 | Jun 30, 2020 | $1.81M | +9.5% |
| Q1 FY2020 | Mar 31, 2020 | $145.93K | -84.8% |
| Q4 FY2019 | Dec 31, 2019 | $1.18M | -51.8% |
| Q3 FY2019 | Sep 30, 2019 | $761.61K | +14.1% |
| Q2 FY2019 | Jun 30, 2019 | $1.66M | -14.4% |
| Q1 FY2019 | Mar 31, 2019 | $961.28K | -61.1% |
| Q4 FY2018 | Dec 31, 2018 | $2.46M | 0.0% |
| Q3 FY2018 | Sep 30, 2018 | $667.63K | -40.6% |
| Q2 FY2018 | Jun 30, 2018 | $1.94M | +10.9% |
| Q1 FY2018 | Mar 31, 2018 | $2.47M | -2.2% |
| Q4 FY2017 | Dec 31, 2017 | $2.46M | -7.7% |
| Q3 FY2017 | Sep 30, 2017 | $1.12M | -69.2% |
| Q2 FY2017 | Jun 30, 2017 | $1.75M | – |
| Q1 FY2017 | Mar 31, 2017 | $2.52M | – |
| Q4 FY2016 | Dec 31, 2016 | $2.67M | – |
| Q3 FY2016 | Sep 30, 2016 | $3.65M | – |
See a number that looks wrong?